Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
Fibroblast growth factor (FGF)-inducible 14 (Fn14) activates the classical and alternative NFκB (nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells) signaling pathway but also enhances tumor necrosis factor (TNF)-induced cell death. Fn14 expression is upregulated in non-hematopoietic c...
Main Authors: | Olena Zaitseva, Annett Hoffmann, Margaretha Löst, Mohamed A. Anany, Tengyu Zhang, Kirstin Kucka, Armin Wiegering, Christoph Otto, Harald Wajant |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1194610/full |
Similar Items
-
Erratum: Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
by: Frontiers Production Office
Published: (2023-12-01) -
Regulation of Tissue Responses: The TWEAK/Fn14 Pathway and other TNF/ TNFR Superfamily Members that Can Signal through noncanonical NFkB
by: Linda C Burkly
Published: (2015-03-01) -
Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy
by: Olena Zaitseva, et al.
Published: (2022-10-01) -
Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
by: Kirstin Kucka, et al.
Published: (2021-02-01) -
Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists
by: George Fromm, et al.
Published: (2023-09-01)